Use of breast imaging-reporting and data system (BI-RADS) ultrasound classification in pediatric and adolescent patients overestimates likelihood of malignancy

医学 双雷达 乳房成像 恶性肿瘤 医学诊断 放射科 女性乳房发育 乳腺癌 超声波 乳腺超声检查 回顾性队列研究 活检 癌症 乳腺摄影术 病理 内科学
作者
John R. Davis,Juliana Liang,Albert T. Roh,Laurel Kittrell,Matthew Petterson,Lisa M. Winton,Mary J. Connell,Rebecca K. Viscusi,Ian K. Komenaka,Ramin Jamshidi
出处
期刊:Journal of Pediatric Surgery [Elsevier BV]
卷期号:56 (5): 1000-1003 被引量:5
标识
DOI:10.1016/j.jpedsurg.2020.12.025
摘要

Abstract

Background/Purpose: Breast masses in the pediatric population cause patient and family concern, partially driven by public awareness of adult breast cancer. However, the spectrum of breast masses in children differs greatly from that in adults, and malignancy is exceedingly rare. The American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) ultrasound-based classification system is the diagnostic standard, yet no study has validated BI-RADS in pediatric patients. This study compares BI-RADS classification with histologic diagnoses to evaluate BI-RADS validity in pediatric patients. Methods: Multicenter retrospective evaluation of breast masses in patients under 21 years. Ultrasound reports were compared with histologic diagnoses. Results: There were 283 patients with breast pathology results after excluding clinical diagnoses of gynecomastia. Mean age was 16.9 (SD 2.3), ranging 10–20 years. 227 had pre-operative ultrasounds, and 84% (191/227) were assigned a BI-RADS category. BI-RADS 4 was the most frequent category (55%, n = 124), by definition predicting 2 – 95% likelihood of malignancy. However, pathology was benign in all patients. Conclusions: The current BI-RADS categorization system overestimates cancer risk when applied to pediatric patients. BI-RADS scores should not be assigned to pediatric patients, and BIRADS-defined recommendations for biopsy should be disregarded. A pediatric-specific classification system could be useful.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
LiyangZ发布了新的文献求助100
1秒前
2秒前
百里如雪发布了新的文献求助10
3秒前
Rita发布了新的文献求助10
4秒前
HOPKINSON发布了新的文献求助10
5秒前
无辜的南瓜完成签到,获得积分10
6秒前
VDC应助guozizi采纳,获得30
6秒前
6秒前
youyouzi完成签到 ,获得积分10
7秒前
Yh发布了新的文献求助10
8秒前
9秒前
桐桐应助zhouleiwang采纳,获得10
9秒前
小崔读研发布了新的文献求助10
11秒前
迷路桃子发布了新的文献求助30
12秒前
asdf发布了新的文献求助10
12秒前
NexusExplorer应助呵呵采纳,获得10
12秒前
12秒前
13秒前
走四方应助风中天宇采纳,获得10
13秒前
FashionBoy应助力量采纳,获得10
16秒前
共享精神应助HOPKINSON采纳,获得10
16秒前
18秒前
大个应助顺心凡采纳,获得10
18秒前
18秒前
小蘑菇应助薛定谔的猴儿采纳,获得10
18秒前
19秒前
21秒前
时尚数据线完成签到,获得积分10
21秒前
22秒前
文献看不懂应助York Chang采纳,获得10
22秒前
眯眯眼的衬衫应助asdf采纳,获得10
22秒前
24秒前
24秒前
24秒前
megumiiii完成签到,获得积分10
24秒前
呵呵发布了新的文献求助10
24秒前
seducement完成签到,获得积分20
25秒前
27秒前
二狗子发布了新的文献求助10
28秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Continuum Thermodynamics and Material Modelling 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 1000
CRC Handbook of Chemistry and Physics 104th edition 1000
Izeltabart tapatansine - AdisInsight 600
An International System for Human Cytogenomic Nomenclature (2024) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3769376
求助须知:如何正确求助?哪些是违规求助? 3314591
关于积分的说明 10172117
捐赠科研通 3029740
什么是DOI,文献DOI怎么找? 1662441
邀请新用户注册赠送积分活动 794966
科研通“疑难数据库(出版商)”最低求助积分说明 756475